SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
1.550
-0.060 (-3.73%)
At close: Aug 13, 2025, 4:00 PM
1.530
-0.020 (-1.29%)
After-hours: Aug 13, 2025, 7:59 PM EDT

SLS Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-26.26-30.88-37.34-41.3-20.7-16.76
Upgrade
Asset Writedown & Restructuring Costs
---105.7-
Upgrade
Stock-Based Compensation
1.761.562.091.731.010.58
Upgrade
Other Operating Activities
0.580.560.490.13-4.42-0.11
Upgrade
Change in Accounts Payable
-3.05-2.142.31.21-2.51-0.84
Upgrade
Change in Unearned Revenue
-----5.65.6
Upgrade
Change in Other Net Operating Assets
-4.39-4.511.044.430.51.11
Upgrade
Operating Cash Flow
-31.36-35.4-31.41-23.81-26.02-10.42
Upgrade
Sale (Purchase) of Intangibles
---5.5-4.5--
Upgrade
Investing Cash Flow
---5.5-4.5--
Upgrade
Issuance of Common Stock
47.5746.8222.3524.0812.0738.44
Upgrade
Repurchase of Common Stock
-0.06-0.06-0.03---
Upgrade
Financing Cash Flow
47.5146.7622.3224.0812.0738.44
Upgrade
Net Cash Flow
16.1511.36-14.6-4.23-13.9528.03
Upgrade
Free Cash Flow
-31.36-35.4-31.41-23.81-26.02-10.42
Upgrade
Free Cash Flow Margin
----2380.90%-342.38%-548.26%
Upgrade
Free Cash Flow Per Share
-0.38-0.58-1.13-1.23-1.68-1.31
Upgrade
Levered Free Cash Flow
-21.63-24.25-28.94-11.87-18.69-3.6
Upgrade
Unlevered Free Cash Flow
-21.63-24.25-28.94-11.87-18.69-3.6
Upgrade
Change in Working Capital
-7.44-6.653.355.64-7.625.87
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q